Fig. 2: Estimated absolute event-free survival gains with comprehensive medical therapy. | Nature Medicine

Fig. 2: Estimated absolute event-free survival gains with comprehensive medical therapy.

From: Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction

Fig. 2

Kaplan–Meier estimated curves for patients starting at 65 years of age for survival free from the primary endpoint (cardiovascular death or worsening HF event) in the overall HFmrEF/HFpEF population (left) and in individuals with HFmrEF/HFpEF with a LVEF below normal <60% (right). Residual event-free lifespan was estimated using the area under the survival curve up to a maximum of 100 years of age.

Back to article page